Data test protection is constituted by information resulting from tests conducted with a novel molecule, which have determined the efficacy and safety of it.
Data test protection is constituted by information resulting from tests conducted with a novel molecule, which have determined the efficacy and safety of it.
Decision 486 of the Andean Community provides the ability to protect this information in terms of exclusivity. It also allows each country member the choice of whether or not to include these periods of exclusivity in their territory.
Also, Legislative Decree No. 1072 provides for the protection of data tests in the registration process of a new chemical entity (NCE) for a period less than the validity period of a health registration, that is, less than five years, counted from the date it was granted the registration in Peru or from the first commercial approval worldwide, for the case where the registration is based on such an approval.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Data test protection, NCE, pharmaceuticals, chemicals
